Oral drug to prevent diabetic blindness

A new study has shown that an oral medication called "Danicaptide" may protect against the development of non-proliferative diabetic retinopathy, an early stage of the disease that damages blood vessels in the eye and increases the risk of blindness. The results demonstrated that the medication reduces fluid leakage and swelling in the retina, matching the effectiveness of current treatments that require repeated intraocular injections, while being safe and easy to use. It is believed that the drug could replace or complement surgical treatments and offers a non-invasive, preventative approach to preserve vision. However, further clinical trials are needed to confirm its long-term efficacy.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل